Where does UMC Utrecht Holding B.v. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), UMC Utrecht Holding B.v. ranks #7,206 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does UMC Utrecht Holding B.v. hold?

UMC Utrecht Holding B.v. holds 46 US utility patents granted between 2016 and 2025, spanning 22 technology areas.

What is UMC Utrecht Holding B.v.'s Innovation Score?

UMC Utrecht Holding B.v. has an Innovation Score of 47.4 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does UMC Utrecht Holding B.v. focus on?

UMC Utrecht Holding B.v.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 16 patents. Grants appear in 22 CPC subclasses total.

Is UMC Utrecht Holding B.v.'s patent grant rate increasing or decreasing?

UMC Utrecht Holding B.v.'s recent grant velocity is +182% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for UMC Utrecht Holding B.v.'s patents?

UMC Utrecht Holding B.v.'s patents average 16.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the UMC Utrecht Holding B.v. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

UMC Utrecht Holding B.v.

USPTO PatentsView assignee record - 46 granted patents across 22 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, UMC ranks #7,206 of 50,000 tracked US assignees by granted-patent volume, with 46 patents across 22 technology areas.

#7,206
of 50,000 US assignees by volume: Top 19%
by Innovation Score (47.4/100): 16.7
avg claims per patent: +182%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7206 · Foreign Corporation #7,206 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,206/50,000
PHOTO-FINISH THE J DAVID GLADSTON…
CPC-FOCUS A61B · 22 areas
INNOV-PAR 47.4/100
CLAIMS-RICH 16.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +182% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: THE J. David Gladstone Institutes (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Everseen · near

47
Imba—institut Für Mo… · near

47
National University… · near

47
Ontario Institute Fo… · near

47
UMC Utrecht Holding… · this assignee

47
3D Lighting Innovati… · lowest

7

What this shows UMC Utrecht Holding B.v. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-SURGE, BOOK-FULL. Volume places it #7,206 of 50,000; Innovation Score 47.4/100 sits in the top 19% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is THE J. David Gladstone Institutes (±0 grants).

Portfolio overview

UMC Utrecht Holding B.v. has been granted 46 US utility patents between 2016 and 2025, placing UMC Utrecht Holding B.v. at #7,206 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, UMC Utrecht Holding B.v. is one of the more focused assignees in the PatentsView dataset. By volume, UMC sits between THE J. David Gladstone Institutes (46 patents, rank #7,201) and UPM Raflatac OY (46 patents, rank #7,209) - the closest US assignees by grant volume. The composite Innovation Score of 47.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 31 grants, compared with 11 in the 2015–2019 window, a +182% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. UMC Utrecht Holding B.v.'s 16.7 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 22 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

THE J David Glads…

46
The Sollami

46
Tomtom Traffic B V

46
Tomey

46
Unity OPTO Techno…

46
University Colleg…

46
UniversitÉ Libre…

46
UPM Raflatac OY

46
UMC Utrecht Holdi… ◀

46

What this shows UMC holds 46 patents at rank #7,205, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near UMC

By rank, the assignees closest to #7,205 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in UMC's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for UMC, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (47 here).

National University Corporation NARA Institute OF Science AND Technology 47 Everseen Limited 47 Ontario Institute For Cancer Research (oicr) 47 Imba—institut Für Molekulare Biotechnologie Gmbh 47

UMC's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

UMC Utrecht Holding B.v. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	6.5%
2017	2	4.3%
2018	5	10.9%
2019	1	2.2%
2020	5	10.9%
2021	9	19.6%
2022	1	2.2%
2023	9	19.6%
2024	7	15.2%
2025partial year	4	8.7%

Which technologies does UMC Utrecht Holding B.v. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 16

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 14

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 11

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10

C07K - PEPTIDES 8

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 6

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 4

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 4

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 4

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 3

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 3

B23D - PLANING; SLOTTING; SHEARING; BROACHING; SAWING; FILING; SCRAPING; LIKE OPERATIONS FOR WORKING METAL BY REMOVING MATERIAL, NOT OTHERWISE PROVIDED FOR 2

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 2

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 2

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#7,206

of 50,000 tracked assignees

Innovation Score

47.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.